GERN Q4 2019 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$171,000-54.4% YoY

Gross Profit

-$24M-14007.0% margin

Operating Income

-$30M-17548.5% margin

Net Income

-$29M-17000.0% margin

EPS (Diluted)

$-0.15

QoQ Revenue Growth

+30.5%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$166M

Total Liabilities

$30M

Stockholders' Equity

$135M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$171,000	$375,000	-54.4%
Gross Profit	-$24M	-$4M	-548.4%
Operating Income	-$30M	-$10M	-212.9%
Net Income	-$29M	-$7M	-298.2%